Roberto Contieri
@RobertoContieri
Urologist @istitutotumori via @HumanitasMilano @MDAndersonNews @NKI_nl Ass. member @EAU_YAUrotheli Member @IBCG_BladderCA
A 🧵 on our recent study on surveillance for IR-NMIBC @EurUrolOncol authors.elsevier.com/c/1l7pU_wtP00L… There is limited evidence on follow-up for IR-NMIBC. We used data from >2000 primary Ta–T1 NMIBC to stratify IR-NMIBC by recurrence risk and propose a risk-adapted follow-up approach.
Navigating the non-muscle-invasive bladder cancer space can be challenging. Thank you @UroDocAsh and @urotoday for the great discussion and the invite. @uc_health @uofcincycancer
Nadofaragene firadenovec: Efficacy, dosing, and real-world performance in BCG-unresponsive #NMIBC. @AlbertoMartini_ @CincyUrology joins @UroDocAsh @MDAndersonNews to discuss treatment sequencing in BCG-unresponsive non-muscle invasive #BladderCancer. #WatchNow >…
Opening the 6th URONEWS International Meeting @istitutotumori with an outstanding live surgery session: SP transvesical RARP by @ricautor MP RARP by @Ruben_De_Groote Complex RAPN by S. Perdoná Lap prostatectomy by M. Falsaperla Technique, vision, and surgical excellence! 👏👏
Just wrapped up the Delphi Consensus Meeting on SP Retroperitoneal Surgery in Naples 🇮🇹 A unique opportunity to engage with leading international experts in da Vinci SP robotic surgery. Great discussions and valuable insights. Results and statements coming soon, stay tuned
Just returned from the #UroOnco25. Always a pleasure to reconnect with colleagues and friends. Grateful to @UroMoschini and Prof. @foxal72 for the invitation and the opportunity to be part of such a high-level meeting.
Our team is in Sevilla for #UROonco25 📩 #NMIBC Deintensify LG Biomarkers to ⬇️ cystoscopy in HG #MIBC ctDNA is the future #UTUC Tailored patient care Go for kidney-sparing treatment @Uroweb @EAU_Uroonco @EAUYAUrology
Nicely done @JoshMeeks @Uromigos @IBCG_BladderCA
@JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved. spotifycreators-web.app.link/e/szAiuFvyaUb
Honored and humbled to receive the Boccafoschi Award for my research in #bladdercancer from UROP, in the wonderful setting of Chia Laguna. Grateful to the scientific committee for this meaningful recognition.
Here’s the thread on our newly published editorial on immediate radical cystectomy in very high-risk patients. Congrats to @josedsh the whole team! @Uroweb @EUplatinum
📣 Very High-risk NMIBC: real-world data challenge guidelines on upfront radical cystectomy. Happy to share our @EUplatinum editorial Thanks @UroDocAsh, @RobertoContieri , @Renate_Pichler , #PietroScilipoti, @niyatilobo for your support 🙏 #BladderCancer #Urology #Oncology
Congratulations on the success of the @Synergy_Uro It was a real pleasure to return to my med school —thanks to @PandolfoSD and the scientific committee. Great to host so many friends in Naples and, most importantly, introduce them to pizza fritta!
🧠 Multidisciplinary Tumor Board now live at #Synergy! 🎙️ Moderated by Dr. Roberto Contieri & Dr. Marco Finati A stellar expert panel on stage: Prof.s Pradere, Formisano, Imbriaco, Pacelli & Goodyear 🔍🩺 Real cases, real decisions — collaboration at its finest! 🤝💬
Great meeting in Naples! @EAU_YAUrotheli present! Thanks to the organisers @PandolfoSD @danieleamparore @Ric_Campi @Uroweb